Rhythm Biosciences (ASX:RHY) 3-Year EBITDA Growth Rate

: -15.60% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

Rhythm Biosciences's EBITDA per Share for the six months ended in Dec. 2023 was A$-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was -15.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -21.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Rhythm Biosciences was -15.60% per year. The lowest was -23.60% per year. And the median was -18.80% per year.

Competitive Comparison

For the Diagnostics & Research subindustry, Rhythm Biosciences's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rhythm Biosciences 3-Year EBITDA Growth Rate Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Rhythm Biosciences's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Rhythm Biosciences's 3-Year EBITDA Growth Rate falls into.

Rhythm Biosciences 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Rhythm Biosciences (ASX:RHY) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Rhythm Biosciences 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Rhythm Biosciences's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhythm Biosciences (ASX:RHY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rhythm Biosciences Ltd (ASX:RHY) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

0RY:Germany

Address

30 Flemington Road, Bio21 Institute, Parkville, Melbourne, VIC, AUS, 3010

Website

https://www.rhythmbio.com

Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. Geographically, the company operates only in Australia.

Rhythm Biosciences (ASX:RHY) Headlines

No Headlines